In a recent study (Garcia et al., 2023), we introduced a method to identify EV surface proteins with the potential to serve as biomarkers in non-alcoholic fatty liver disease (NAFLD). The gene discussed is PROS1; the disease is metabolic dysfunction-associated steatotic liver disease.